Large-scale testing (Phase 3)Study completedNCT02242487
What this trial is testing
Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 325